Copyright (c) 2017 AJC
This work is licensed under a Creative Commons Attribution 4.0 International License.
Antibacterial Evaluation of Benzo[b]pyrazolo[3,4-b]-1,6-naphthyridines, Pyrazolo[3,4-b]pyrido-[2',3'-b]-1,6-naphthyridines and Dipyrazolo[3,4-b];3',4'-h]-1,6-naphthyridines
Asian Journal of Chemistry,
Vol. 29 No. 1 (2017): Vol 29 Issue 1
Abstract
Antibacterial screening of benzo[b]pyrazolo[3,4-b]-1,6-naphthyridines, pyrazolo[3,4-b]pyrido[2',3'-b]-1,6-naphthyridines and dipyrazolo-[3,4-b];3',4'-h]-1,6-naphthyridines has been performed by dics diffusion method. Cefotaxime, enoxabid and dibkacin were used as a reference and antibacterial activity was assessed by measuring the diameter of the growth-inhibition zone.
Keywords
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX
- (a) H.I. El-Subbagh, S.M. Abu-Zaid, M.A. Mahran, F.A. Badria and A.M. Al-Obaid, J. Med. Chem., 43, 2915 (2000); (b) R.R. Kumar, S. Perumal, P. Senthilkumar, P. Yogeeswari and D. Sriram, Bioorg. Med. Chem. Lett., 17, 6459 (2007); (c) N.V. Sviridenkova, S.Z. Vatsadze, M.A. Manaenkova and N.V. Zyk, Russ. Chem. Bull., 54, 2590 (2005).
- A.E.G. Hammam, M.A. Sharaf and N.A.A. El-Hafez, Indian J. Chem., 40B, 213 (2001).
- A. Gangjee, Y. Zeng, J.J. McGuire and R.L. Kisliuk, J. Med. Chem., 45, 5173 (2002).
- J.S. Skotnicki, 2-Amino-3-cyano-bicyclic Pyridines/Pyrazines as Inhibitors of Interleukin 1, US Patent 4902685 (1990).
- J. Blagg, M.J. Fray, M.L. Lewis, J.P. Mathias, M.H. Stefaniak and A. Stobie, Quinazoline Compounds Useful in Therapy, PCT Int. Appl. WO 2003076427 A1 (2003).
- T. Ohta, S. Komoriya, T. Yoshino, K. Uoto, Y. Nakamoto, H. Naito, A. Mochizuki, T. Nagata, H. Kanno, N. Haginoya, K. Yoshikawa, M. Nagamochi, S. Kobayashi and M. Ono, Diamine Derivatives, PCT Int. Appl. WO 2004058715 A1 (2004).
- (a) A.D. Broom, J.L. Shim and G.L. Anderson, J. Org. Chem., 41, 1095 (1976); (b) E.M. Grivsky, S. Lee, C.W. Sigel, S.D. Duch and C.A. Nichol, J. Med. Chem., 23, 327 (1980).
- (a) J. Matsumoto and S. Minami, J. Med. Chem., 18, 74 (1975); (b) N. Suzuki, Chem. Pharm. Bull. (Tokyo), 28, 761 (1980); (c) V. Oakes and H.N. Rydon, J. Chem. Soc., 4433 (1956); (d) J.I. DeGraw, R.L. Kisliuk, Y. Gaumont and C.M. Baugh, J. Med. Chem., 17, 470 (1974); (e) A.V. Zakharov, M.Yu. Gavrilov, G.N. Novoselova, M.I. Vakhrin and M.E. Konshin, Pharm. Chem. J., 30, 703 (1996).
- A.B. Deyanov, R.K. Niyazov, F.Y. Nazmetdinov, B.Y. Syropyatov, V.E. Kolla and M.E. Konshin, Pharm. Chem. J., 25, 248 (1991).
- R.E. Heckler and G.P. Jourdan, Eur. Pat. Appl. EP, 414386, A127 (1991); Chem. Abstr., 115, 71630 (1991).
- A. Agarwal, Ramesh, Ashutosh, N. Goyal, P.M.S. Chauhan and S. Gupta, Bioorg. Med. Chem., 13, 6678 (2005).
- A.R. de Azevedo, I.C.P.P. Frugulhetti, M.A. Khan, S. Khakwani and A.M.R. Bernardino, Heterocycl. Commun., 8, 47 (2002).
- A.W. Bauer, W.M.M. Kirby, J.C. Serris and M. Turck, J. Clin. Pathol., 45, 493 (1966).
References
(a) H.I. El-Subbagh, S.M. Abu-Zaid, M.A. Mahran, F.A. Badria and A.M. Al-Obaid, J. Med. Chem., 43, 2915 (2000); (b) R.R. Kumar, S. Perumal, P. Senthilkumar, P. Yogeeswari and D. Sriram, Bioorg. Med. Chem. Lett., 17, 6459 (2007); (c) N.V. Sviridenkova, S.Z. Vatsadze, M.A. Manaenkova and N.V. Zyk, Russ. Chem. Bull., 54, 2590 (2005).
A.E.G. Hammam, M.A. Sharaf and N.A.A. El-Hafez, Indian J. Chem., 40B, 213 (2001).
A. Gangjee, Y. Zeng, J.J. McGuire and R.L. Kisliuk, J. Med. Chem., 45, 5173 (2002).
J.S. Skotnicki, 2-Amino-3-cyano-bicyclic Pyridines/Pyrazines as Inhibitors of Interleukin 1, US Patent 4902685 (1990).
J. Blagg, M.J. Fray, M.L. Lewis, J.P. Mathias, M.H. Stefaniak and A. Stobie, Quinazoline Compounds Useful in Therapy, PCT Int. Appl. WO 2003076427 A1 (2003).
T. Ohta, S. Komoriya, T. Yoshino, K. Uoto, Y. Nakamoto, H. Naito, A. Mochizuki, T. Nagata, H. Kanno, N. Haginoya, K. Yoshikawa, M. Nagamochi, S. Kobayashi and M. Ono, Diamine Derivatives, PCT Int. Appl. WO 2004058715 A1 (2004).
(a) A.D. Broom, J.L. Shim and G.L. Anderson, J. Org. Chem., 41, 1095 (1976); (b) E.M. Grivsky, S. Lee, C.W. Sigel, S.D. Duch and C.A. Nichol, J. Med. Chem., 23, 327 (1980).
(a) J. Matsumoto and S. Minami, J. Med. Chem., 18, 74 (1975); (b) N. Suzuki, Chem. Pharm. Bull. (Tokyo), 28, 761 (1980); (c) V. Oakes and H.N. Rydon, J. Chem. Soc., 4433 (1956); (d) J.I. DeGraw, R.L. Kisliuk, Y. Gaumont and C.M. Baugh, J. Med. Chem., 17, 470 (1974); (e) A.V. Zakharov, M.Yu. Gavrilov, G.N. Novoselova, M.I. Vakhrin and M.E. Konshin, Pharm. Chem. J., 30, 703 (1996).
A.B. Deyanov, R.K. Niyazov, F.Y. Nazmetdinov, B.Y. Syropyatov, V.E. Kolla and M.E. Konshin, Pharm. Chem. J., 25, 248 (1991).
R.E. Heckler and G.P. Jourdan, Eur. Pat. Appl. EP, 414386, A127 (1991); Chem. Abstr., 115, 71630 (1991).
A. Agarwal, Ramesh, Ashutosh, N. Goyal, P.M.S. Chauhan and S. Gupta, Bioorg. Med. Chem., 13, 6678 (2005).
A.R. de Azevedo, I.C.P.P. Frugulhetti, M.A. Khan, S. Khakwani and A.M.R. Bernardino, Heterocycl. Commun., 8, 47 (2002).
A.W. Bauer, W.M.M. Kirby, J.C. Serris and M. Turck, J. Clin. Pathol., 45, 493 (1966).